A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer

Patients with non-small-cell lung cancer (NSCLC) often have an advanced disease when firstly diagnosed. Bevacizumab is a monoclonal antibody against vascular endothelial growth factor receptor (VEGFR). In this study, we retrospectively analyzed the efficacy of cisplatin, pemetrexed, and bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ke-Jun, Wu, Hai-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673196/
https://www.ncbi.nlm.nih.gov/pubmed/26093089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673196/
https://www.ncbi.nlm.nih.gov/pubmed/26093089

Ejemplares similares